Alice Bexon

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics

Thomas Boyer, Arun J. Sanyal, Guadalupe García–Tsao et al. · Journal of Hepatology · 2010 · 248 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1

Thomas Boyer, Arun J. Sanyal, Guadalupe García–Tsao et al. · Liver Transplantation · 2011 · 120 citations

Medicine, Pharmacotherapy, Surgery +12

Irinotecan Combined With Bolus Fluorouracil, Continuous Infusion Fluorouracil, and High-Dose Leucovorin Every Two Weeks (LV5FU2 Regimen): A Clinical Dose-Finding and Pharmacokinetic Study in Patients With Pretreated Metastatic Colorectal Cancer

Michel Ducreux, Marc Ychou, Jean‐François Seitz et al. · Journal of Clinical Oncology · 1999 · 100 citations

Medicine, Oncology, Pharmacology +17

Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy

David A. Smith, Paul Conkling, Donald Richards et al. · Cancer Immunology Immunotherapy · 2014 · 67 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

Ágnes Ruzsa, Mehmet Şen, Mark D. Evans et al. · Investigational New Drugs · 2014 · 57 citations

Medicine, Oncology, Cancer Pharmacology +9